ABERDEEN STD GOLD ETF TR's ticker is SGOL and the CUSIP is 00326A104. A total of 9 filers reported holding ABERDEEN STD GOLD ETF TR in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $305,000 | -42.3% | 17,676 | -37.9% | 0.41% | +13.3% |
Q1 2022 | $529,000 | -44.3% | 28,450 | -49.5% | 0.36% | +40.9% |
Q4 2021 | $949,000 | +2.9% | 56,372 | +3.0% | 0.26% | -1.5% |
Q3 2021 | $922,000 | -9.3% | 54,731 | -8.6% | 0.26% | -36.8% |
Q2 2021 | $1,017,000 | -14.8% | 59,881 | -17.7% | 0.41% | +11.3% |
Q1 2021 | $1,193,000 | -16.4% | 72,741 | -6.9% | 0.37% | -39.2% |
Q4 2020 | $1,427,000 | -3.8% | 78,121 | -4.5% | 0.61% | -7.9% |
Q3 2020 | $1,484,000 | +1.4% | 81,796 | -4.2% | 0.66% | +7.5% |
Q2 2020 | $1,463,000 | +5.6% | 85,401 | -6.7% | 0.62% | -0.3% |
Q1 2020 | $1,386,000 | -4.7% | 91,511 | -8.1% | 0.62% | +16.6% |
Q4 2019 | $1,455,000 | -7.1% | 99,575 | +801.5% | 0.53% | -15.2% |
Q3 2019 | $1,567,000 | -2.7% | 11,046 | -6.7% | 0.62% | -14.6% |
Q2 2019 | $1,610,000 | +13.1% | 11,843 | +3.5% | 0.73% | -20.4% |
Q1 2019 | $1,424,000 | -11.1% | 11,440 | -9.7% | 0.92% | +17.9% |
Q4 2018 | $1,601,000 | +9.7% | 12,670 | -0.2% | 0.78% | -0.4% |
Q3 2018 | $1,460,000 | – | 12,690 | – | 0.78% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prostatis Group LLC | 500,689 | $7,585,438 | 10.78% |
Almanack Investment Partners, LLC. | 2,310,779 | $35,008,000 | 7.52% |
Hudock, Inc. | 959,228 | $14,532,000 | 5.71% |
SimpliFi, Inc. | 595,575 | $9,023,000 | 5.64% |
UBP Investment Advisors SA | 405,987 | $6,151,000 | 5.56% |
Allen Capital Group, LLC | 850,481 | $12,885,000 | 3.97% |
CARY STREET PARTNERS INVESTMENT ADVISORY LLC | 84,266 | $1,276,000 | 2.98% |
American Money Management, LLC | 302,921 | $4,589,000 | 2.57% |
WT Wealth Management | 132,453 | $2,006,000 | 2.11% |
FormulaFolio Investments, LLC | 2,385,654 | $36,143,000 | 1.93% |